Thu, Nov 27, 2014, 1:56 PM EST - U.S. Markets closed for Thanksgiving Day

Recent

% | $
Quotes you view appear here for quick access.

Federal National Mortgage Association Message Board

meltdownman1 78 posts  |  Last Activity: Nov 22, 2014 10:01 AM Member since: Aug 12, 1998
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Five chances at the UGAZ 18 High

    by thouchartist Nov 21, 2014 2:13 PM
    meltdownman1 meltdownman1 Nov 22, 2014 10:01 AM Flag

    Are you using Big Charts for calculating the Fib Numbers and if so are those numbers where you expect possible changes in direction in the trend? Also what are you using for overbought or oversold? I had a friend tell me all I need is the MACD and RSI but that seems pretty basic for trading something like NG. I have been paper trading only but my gut instinct for oversold and overbought has been pretty good but based on pure instinct (e.g. nothing continues to go up extremely fast like we have seen here lately). Also people keep talking about the options and how they are slanted towards puts or calls but I don't know how to utilize that indicator. To me that seems like where the big boys are playing and manipulating the trades. Do look at options at all and if so how do use them for fine tuning your trades since they don't have MACD, RSI etc (as far as I know). Thanks again

  • Reply to

    Five chances at the UGAZ 18 High

    by thouchartist Nov 21, 2014 2:13 PM
    meltdownman1 meltdownman1 Nov 21, 2014 3:28 PM Flag

    Chart what graphs/software are using for trending channels? Thanks in advance

  • Reply to

    GBM Ph II Trial

    by gophr4life Nov 19, 2014 8:31 AM
    meltdownman1 meltdownman1 Nov 19, 2014 10:41 PM Flag

    My friend was given a year for his brain cancer. He also stated that it comes from some other place in the body. He also has lung cancer. Got to give up that smoking folks!

    Sentiment: Strong Buy

  • Reply to

    GBM Ph II Trial

    by gophr4life Nov 19, 2014 8:31 AM
    meltdownman1 meltdownman1 Nov 19, 2014 9:50 PM Flag

    You still have to have patients die in the GBM trial to the stats to be correct. If they are not dying then this is a factor. There aren't as many cases of GBM as STS so to be sure of the data then the number of deaths have to be factored in. Everyone can assume that it is the pace of the enrollment but longevity is just as important on the stats. On another note, they are not telling what the patient was being treated for (e.g. STS or GBM etc.).

    Sentiment: Strong Buy

  • Reply to

    GBM Ph II Trial

    by gophr4life Nov 19, 2014 8:31 AM
    meltdownman1 meltdownman1 Nov 19, 2014 4:46 PM Flag

    Not true fish:

    "Although it is too early to make any definitive assessment of the Phase 2b survival data, our early assessment is encouraging," said Sant P. Chawla, M.D., F.R.A.C.P., Director of the Sarcoma Oncology Center, and principal investigator of the trial. "As previously reported, aldoxorubicin has already demonstrated statistically significant improvements in progression-free survival, as well as promising improvements in tumor shrinkage and overall response rates."

    "Even though the clinical trial was not powered to show statistically significant differences in overall survival due to the relatively small number of patients, we are hopeful that a positive trend favoring the aldoxorubicin arm of the trial will be observed," said Steven A. Kriegsman, CytRx President and Chief Executive Officer. "Overall survival is event driven. Only a portion of the required events have occurred – meaning patients are living longer than expected, which is the ultimate goal of our oncology program. We will report overall survival when the expected number of survival events occurs.

    Sentiment: Strong Buy

  • Reply to

    GBM Ph II Trial

    by gophr4life Nov 19, 2014 8:31 AM
    meltdownman1 meltdownman1 Nov 19, 2014 3:41 PM Flag

    Because to have accurate statistics you have to have the patients in the study to die. They haven't been dying...go back and look at the previous releases put out by the company.

    Sentiment: Strong Buy

  • meltdownman1 by meltdownman1 Nov 18, 2014 7:00 PM Flag

    It is not accepting new patients. The studies of current patients is still ongoing until the study on the current patients is complete. Therefore the data for the current study will still be accumulated and analyzed.

    People were talking on this board about the frustration of not having any data yet just a week ago but you have to wait until enough people who have died add up enough of the statistics to see if the data proves that ALDO is superior over Doxy. And yet not enough people were dying and so they were getting frustrated. And now someone who opted to use a hail marry pass and give Aldo a try dies they complain about that. The patient gave it a shot and didn't make it. Have some respect for the family of the patient. The body isn't even cold yet. Christ people give the medicine a chance to see if it works and the statistics support the effectiveness of its application. The company has stated that the data/results wouldn't be out until 2015. You shouldn't be here if you are that paranoid. Buy bonds and sleep better at night.

    Sentiment: Strong Buy

  • Reply to

    Per the FDA's Request....

    by oxotnik1 Nov 18, 2014 2:38 PM
    meltdownman1 meltdownman1 Nov 18, 2014 4:14 PM Flag

    Then quit.

    Sentiment: Strong Buy

  • Reply to

    Cardio Tox

    by nickdidomenico Nov 18, 2014 11:58 AM
    meltdownman1 meltdownman1 Nov 18, 2014 3:58 PM Flag

    Then sell and take the loss, get the tax write off and move on with your life. Why don't you use the argument that the patient shouldn't have even asked for the medicine knowing the risks knowing and that it would screw up some statistical data that would show up against the use of ALDO.

    Sentiment: Strong Buy

  • Reply to

    Cardio Tox

    by nickdidomenico Nov 18, 2014 11:58 AM
    meltdownman1 meltdownman1 Nov 18, 2014 3:52 PM Flag

    The body isn't even cold yet and there has been no autopsy at this point and you are demanding information? Go ask the family why don't you and avoid having heard it third hand and since you don't even like management you wouldn't believe them anyway no matter what they put out.

    Sentiment: Strong Buy

  • Reply to

    Cardio Tox

    by nickdidomenico Nov 18, 2014 11:58 AM
    meltdownman1 meltdownman1 Nov 18, 2014 3:47 PM Flag

    Why give it out so some short can spin his way? Is that what you want? There are privacy issues to think about whether you like it or not. Sorry but that is the law and we don't need another lawsuit out there from disclosing personal information.

    If you are not sure then you can sell your shares Nick and buy bonds.

    Sentiment: Strong Buy

  • Reply to

    Cardio Tox

    by nickdidomenico Nov 18, 2014 11:58 AM
    meltdownman1 meltdownman1 Nov 18, 2014 2:12 PM Flag

    First you are assuming that the patient was in the US. That was not disclosed. If the patient was then the patient's family has a right to non disclosure. HIPA rules.

    Sentiment: Strong Buy

  • Reply to

    Cardio Tox

    by nickdidomenico Nov 18, 2014 11:58 AM
    meltdownman1 meltdownman1 Nov 18, 2014 1:10 PM Flag

    Then sell all your shares and buy bonds. You will sleep better at night.

    Sentiment: Strong Buy

  • Reply to

    CYTR on Seeking Alpha Instablog

    by johnsonstarfish_0212 Nov 17, 2014 4:47 PM
    meltdownman1 meltdownman1 Nov 18, 2014 12:00 PM Flag

    Management made the right conservative decision. I'm sorry that this didn't work for the patient but I applaud him or her for taking the chance on this drug.

    Sentiment: Strong Buy

  • Reply to

    CYTR on Seeking Alpha Instablog

    by johnsonstarfish_0212 Nov 17, 2014 4:47 PM
    meltdownman1 meltdownman1 Nov 18, 2014 10:52 AM Flag

    Well we now know who to follow ahead of the news before it comes out to the general public. This will be your queue to nab more shares if the company has a very successful drug on their hands! Who was the author of the blog and how do we best follow him?

    Sentiment: Strong Buy

  • Reply to

    how to sleep at night

    by eskimo_pie22 Nov 17, 2014 3:38 PM
    meltdownman1 meltdownman1 Nov 18, 2014 6:37 AM Flag

    Actually I was looking to see if the amount of options that are out there might be an indication of whether the ETF is overbought or oversold since they are usually bought by more sophisticated investors. The recent spike upwards on UNG and the rest of these came off of what I read on this board as being extremely heavy on the shorting side and it seemed to me to be inevitable that we would have a large increase to the upside. Which brings me to the other question of where do you guys go to check for the amount of shorting that is going on. Thanks in advance. Just paper trading this for now until I get more educated on NG and the indicators out there.

  • Reply to

    how to sleep at night

    by eskimo_pie22 Nov 17, 2014 3:38 PM
    meltdownman1 meltdownman1 Nov 17, 2014 10:58 PM Flag

    eskimo...any good books to read on trading options for the natural gas market that would be good for someone wanting to learn how to do it? Thanks in advance.

  • Curious when you folks have been here a while are going to jump on DGAZ. The 52 week low was about 2.50-2.60. Are you going to jump back in at those levels or wait even lower? Thanks in advance.

  • With the dip in oil prices does anyone know at what point/price will those plants that have the option of switching over to oil vice using gas use oil for electric generation?

  • meltdownman1 by meltdownman1 Nov 14, 2014 7:47 PM Flag

    The extended forecast for upstate NY is mid to upper 40's the last week of November. However, during next week the temps are in the mid to lower 30's. Will the producers lower production due to line freeze next week and pick up production again during the last week of November seeing it as an additional opportunity to produce or will they pretty much make the rigs dormant next week until spring. Thanks in advance

FNMA.OB
2.10-0.12(-5.41%)Oct 30 2:37 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.